RxDoctor Payments Data

Richard Williams, MD

Obstetrics & Gynecology · San Dimas, CANPI 1467457390

Payments from drug & device makers

$2,121in general payments, 2019–2025

Across 92 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$973
  • Hologic Sales And Service, LLC$292
  • Therapeuticsmd, Inc.$127
  • Mayne Pharma Commercial LLC$111
  • Novo Nordisk$94
  • Sage Therapeutics, LLC$88
  • plus $436 from 15 others

What the payments were for

  • Travel & lodging$1015%
  • Food & beverage$2,00795%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,121 in reported general payments places this provider in the 75th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California

Medicare billing

Part B allowed, 2024
$25,157
Medicare patients
89
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EstringEstradiol43$22,426
Estradiol259$20,594
ImvexxyEstradiol14$5,804
Vivelle-DotEstradiol11$2,946
ProgesteroneProgesterone, Micronized45$2,206
Estradiol (Twice Weekly)Estradiol11$897
Estradiol (Once Weekly)Estradiol11$755
Medroxyprogesterone Acetate34$352
Metronidazole11$233
Alprazolam16$167
Acyclovir11$154
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$133
Triamcinolone Acetonide26$94
Zolpidem Tartrate11$92

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEstring$41$22,42643 claims
Therapeuticsmd, Inc.Imvexxy$127$5,80414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,784 obstetrics & gynecology providers in California.

Other obstetrics & gynecology in San Dimas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →